LUKASZ SZARPAK to Psilocybin
This is a "connection" page, showing publications LUKASZ SZARPAK has written about Psilocybin.
Connection Strength
0.239
-
Efficacy and safety of psilocybin in the treatment of Major Depressive Disorder (MDD): A dose-response network meta-analysis of randomized placebo-controlled clinical trials. Psychiatry Res. 2025 Feb; 344:116337.
Score: 0.239